Roche’s Tecentriq recommended for EU approval to treat lung cancer form
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – The European Medicine Agency’s Committee for…